Effect of D-penicillamine on neuromuscular junction in patients with Wilson disease.
Komal Kumar
R N
RN
Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.
Patil
S A
SA
Taly
A B
AB
Nirmala
M
M
Sinha
S
S
Arunodaya
G R
GR
D000293:Adolescent; D000328:Adult; D001323:Autoantibodies / Q000097:blood / Q000276:immunology; D002648:Child; D015331:Cohort Studies; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005500:Follow-Up Studies; D006527:Hepatolenticular Degeneration / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D008297:Male; D009157:Myasthenia Gravis / Q000139:chemically induced / Q000209:etiology* / Q000276:immunology; D009469:Neuromuscular Junction / Q000187:drug effects*; D010396:Penicillamine / Q000009:adverse effects* / Q000627:therapeutic use; D011446:Prospective Studies; D011950:Receptors, Cholinergic / Q000276:immunology; D016037:Single-Blind Method
D001323:Autoantibodies; D011950:Receptors, Cholinergic; D010396:Penicillamine